MMP2 and lip and oral cavity carcinoma: Yang et al., (2010) demonstrated that the TCE could inhibit invasion and metastases of SCC-4 oral cancer by suppressing expression of urokinase plasminogen activator (u-PA), matrix metalloproteinase 2(MMP-2), and MMP-9 both in protein and mRNA levels (Yang et al., 2010).